Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The presynaptic cholinergic nerve terminal SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor) exocytosis machinery is a specialized protein complex responsible for the release of acetylcholine into the neuromuscular junction and autonomic synapses (Jahn & Scheller, 2006). It primarily consists of three key proteins: synaptobrevin (also known as vesicle-associated membrane protein or VAMP) on the vesicle membrane, and syntaxin-1 and SNAP-25 on the presynaptic plasma membrane (Rossetto et al., 2014). These proteins assemble into a stable four-helix bundle that pulls the vesicle and plasma membranes into close proximity, facilitating membrane fusion and subsequent neurotransmitter exocytosis. This machinery is the primary target for botulinum neurotoxins (BoNTs), which act as highly specific zinc-dependent endopeptidases (Dressler et al., 2005). By cleaving specific components of the SNARE complex—such as SNAP-25 by BoNT/A or synaptobrevin by BoNT/B—these toxins prevent the formation of the fusion complex, effectively blocking cholinergic transmission (Dhaked et al., 2010). This mechanism is therapeutically exploited to treat conditions characterized by muscle overactivity, such as cervical dystonia, spasticity, and chronic migraine, as well as for cosmetic applications.
Proteolytic cleavage of SNARE proteins (SNAP-25, Syntaxin, or VAMP), preventing the formation of the SNARE complex and inhibiting acetylcholine release.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex (SNARE complex) (SNARE complex).